Colleges
Judit Simon
MD (Hons), BA, BSc, MSc, DPhil (Oxford), FFPH
Visiting Professor of Cognitive Health Economics
Oxford Mental Health Economics and Policy
My main expertise lies in health care optimisation through applied and methodological economic evaluation and outcomes research primarily in the fields of mental health, public health, perinatal and palliative care, and various chronic diseases. Other research areas include cost-effective clinical guideline/HTA development; broader system-level evaluation and international comparison of health services and health systems.
I have been Visiting Professor of Cognitive Health Economics at the Department of Psychiatry since 2014, with relevant mental health economics research collaborations spanning over 25 years. These include NICE mental health clinical guideline developments, economic evaluations alongside randomised controlled trials (CEQUEL, OXTEXT, OCTET, PreDicT, PAX-D, PETRUSHKA), development of the OxCAP-MH capability well-being instrument, and assessing the cost of bipolar disorders in the UK and the physical comorbidity costs of mental disorders in Europe. Other linked works cover the Horizon 2020 PECUNIA project to improve the methods of (mental) health economic evaluations, co-authoring the New Oxford Textbook of Psychiatry, academic advisory roles (EBC VoT2, Oxford Health BRC, UK MHM), and the Lancet Psychiatry Commission on Climate Change and Mental Health.
For further details, see main profile at the Department of Health Economics, Medical University of Vienna.
Recent publications
A taxonomy of the process in implementation science: the Global Impact Analytics Framework (GIAF)
Journal article
Salvador-Carulla L. et al, (2026), Implementation Science Communications, 7
Correction: A taxonomy of the process in implementation science_ the Global Impact Analytics Framework (GIAF) (Implementation Science Communications, (2026), 7, 1, (26), 10.1186/s43058-025-00824-8)
Journal article
Salvador-Carulla L. et al, (2026), Implementation Science Communications, 7
A Decision-Support System to Personalize Antidepressant Treatment in Major Depressive Disorder: A Randomized Clinical Trial.
Journal article
Cipriani A. et al, (2026), JAMA, 335, 1219 - 1231
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial.
Journal article
Perić N. et al, (2026), BJPsych Open, 12
Climate-Related and Nature-Based Interventions for Mental Health: An Umbrella Review and Meta-Analysis.
Journal article
Brandt L. et al, (2026), JAMA Psychiatry
Economic evaluations in the palliative and end-of-life care settings: A systematic review of existing evidence, methods and quality.
Journal article
Fischer C. et al, (2026), Palliat Med
Follow-up of suspected child maltreatment cases treated at a tertiary child protection service facility.
Journal article
Mora-Theuer EA. et al, (2026), Eur J Pediatr, 185
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial.
Journal article
Łaszewska A. et al, (2026), Lancet Reg Health Eur, 61
Theoretically Universal, Practically Unequal: Socio-Economic Inequalities in Healthcare Access for Long Covid-19 Patients in Austria.
Journal article
Gamillscheg-Müllner P. et al, (2026), Health Expect, 29
Translation, cross-cultural adaptation, and validation of the Caregiver Indirect and Informal Care Cost Assessment Questionnaire for end-of-life care into Spanish.
Journal article
Lamfre LS. et al, (2026), Palliat Support Care, 24
Association between health literacy and reproductive health knowledge and behavior : A cross-sectional survey among women of reproductive age in Vienna.
Journal article
Rottjakob P. et al, (2026), Wien Klin Wochenschr
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trial.
Journal article
Berger M. et al, (2025), J Affect Disord, 391
Barriers, facilitators, and the role of central coordination: understanding long COVID-19 healthcare access in a universal healthcare system.
Journal article
Gamillscheg-Müllner P. et al, (2025), Arch Public Health, 83
Climate change and mental health: announcing a new Lancet Psychiatry Commission.
Journal article
Brandt L. et al, (2025), Lancet Psychiatry, 12, 811 - 813
Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria.
Journal article
Saly E. et al, (2025), Qual Life Res, 34, 2821 - 2833
